Varlitinib in Combination With mFOLFOX6 for Advanced or Metastatic Gastric Cancer (First Line)
Clinical trial NCT03130790 · COMPLETED
Trial details
- NCT number
- NCT03130790
- Sponsor
- ASLAN Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-31
- Primary completion
- 2018-12-20
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.